Literature DB >> 22390846

Glycopolymer modification on physicochemical and biological properties of poly(L-lysine) for gene delivery.

Dezhong Zhou1, Congxin Li, Yuling Hu, Hao Zhou, Jiatong Chen, Zhengpu Zhang, Tianying Guo.   

Abstract

Poly(L-lysine) (PLL) has excellent plasmid DNA (pDNA) condensation capacity. However, the relatively high cytotoxicity and low transfection efficiency limit its application as gene delivery vectors. Here, well-defined glycopolymers are synthesized by reversible addition fragmentation transfer polymerization and grafted onto PLL to improve the gene delivery performance. After glycopolymer modification, PLL shows reduced cytotoxicity. By regulating the glycopolymer length and amino group substitution degree, the glycopolymer modified PLL can condense pDNA with proper strength, protect the condensed pDNA from degradation and release them in time. Transfection with NIH3T3 and HepG2 cells shows that the glycopolymer modified PLL has improved transfection efficiencies. The low cytotoxicity, effective pDNA protection and enhanced transfection efficiencies indicate that glycopolymer modification would be an effective strategy to improve the polycation properties for gene delivery.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22390846     DOI: 10.1016/j.ijbiomac.2012.02.021

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  2 in total

1.  In-vitro toxicity of carbon nanotube/polylysine colloids to colon cancer cells.

Authors:  Alejandro Ansón-Casaos; Laura Grasa; Desirée Pereboom; José Emilio Mesonero; Alvaro Casanova; María Divina Murillo; María Teresa Martínez
Journal:  IET Nanobiotechnol       Date:  2016-12       Impact factor: 1.847

Review 2.  Glycopolymer code based on well-defined glycopolymers or glyconanomaterials and their biomolecular recognition.

Authors:  Gokhan Yilmaz; C Remzi Becer
Journal:  Front Bioeng Biotechnol       Date:  2014-10-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.